R-loop functions in neuronal gene expression and genome organization
Project Number5R01NS135217-02
Former Number1R01NS135217-01
Contact PI/Project LeaderSARMA, KAVITHA
Awardee OrganizationWISTAR INSTITUTE
Description
Abstract Text
Project Summary
The goal of this proposal is to uncover the mechanistic connection between R-loops and gene expression through
effects on genome architecture to understand how R-loop deregulation can contribute to neurodevelopmental
disorders.
R-loops are poorly understood RNA-containing chromatin structures that accumulate in, and contribute to the
etiology of, several neurodevelopmental disorders. This includes Activity-dependent neuroprotective protein
(ADNP) syndrome, also known as Helsmoortel-Van Der Aa syndrome, which is a rare condition in children that
exhibit signs of autism. At present, how R-loops contribute to neurological disorders like ADNP syndrome is
unclear. Accumulated R loops lead to an increased DNA damage response and can also alter transcription of
neighboring genes. However, the mechanistic basis for R loops-mediated changes in gene expression are
unknown and the functional relevance of this process to disorders like ADNP syndrome is unexplored.
We have made the surprising finding that R-loops are highly enriched at a subset of binding sites for CTCF.
Preliminary data show that R-loops strengthen CTCF interactions with chromatin. We found that conditions
leading to loss or gain of R-loops can decrease or increase CTCF recruitment, respectively, and affect long-
range genome interactions. We recently demonstrated that the activity-dependent neuroprotective protein
(ADNP), a critical protein for brain development, is a site-specific R-loop resolver. ADNP heterozygous missense
or frameshift mutations cause ADNP syndrome, a severe neurodevelopmental disorder. Human induced
pluripotent stem cells (hiPSCs) derived from patients with ADNP syndrome show increased R-loops and CTCF
accumulation at ADNP binding sites. We find that ADNP binding sites are enriched for sequences that are
recognized by the genome architectural protein YY1, which has important functions in regulating enhancer-
promoter interactions especially in the neural lineage. ADNP and YY1 co-localizes at active enhancers. Our
preliminary data also identified changes in DNA methylation in ADNP syndrome hiPSCs that can potentially
impact CTCF and YY1 binding to cause pathogenic genome misfolding and aberrant neural gene expression in
ADNP syndrome. We hypothesize that R-loops have a regulatory function, and that they target CTCF and YY1
to specific genomic sites during neurodifferentiation. We posit that they may be critical for long-range genome
interactions that reinforce neural lineage specific gene expression programs. We propose to decipher the impact
of R-loop deregulation on genome organization and gene expression in the neural lineage through the lens of
ADNP syndrome. In Aim 1, we will evaluate R-loop mediated regulation of CTCF and YY1 localization during
neurodifferentiation. In Aim 2, we will examine the epigenetic consequences of distinct ADNP syndrome
mutations and their impact on genome regulatory interactions.
Public Health Relevance Statement
Project Narrative
R-loops accumulate in many neurodevelopmental disorders and cancers and can impact the localization of
important epigenetic regulators. Elucidating the mechanisms by which R-loops can alter the epigenetic
landscape during neurodevelopment can aid in identification of new targets for therapeutic intervention in a range
of neurological diseases and cancers where R-loops are deregulated.
National Institute of Neurological Disorders and Stroke
CFDA Code
853
DUNS Number
075524595
UEI
DW1XZMGNFBL4
Project Start Date
01-March-2024
Project End Date
28-February-2029
Budget Start Date
01-March-2025
Budget End Date
28-February-2026
Project Funding Information for 2025
Total Funding
$464,093
Direct Costs
$254,856
Indirect Costs
$209,237
Year
Funding IC
FY Total Cost by IC
2025
National Institute of Neurological Disorders and Stroke
$464,093
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01NS135217-02
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01NS135217-02
Patents
No Patents information available for 5R01NS135217-02
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01NS135217-02
Clinical Studies
No Clinical Studies information available for 5R01NS135217-02
News and More
Related News Releases
No news release information available for 5R01NS135217-02
History
No Historical information available for 5R01NS135217-02
Similar Projects
No Similar Projects information available for 5R01NS135217-02